Showing results (911-920 of 956) with videos related to

Sort By:
Pageof 96
Toxins|July 2, 2021
Wide-Targeted Metabolome Analysis Identifies Potential Biomarkers for Prognosis Prediction of Epithelial Ovarian CancerEiji Hishinuma, Muneaki Shimada, Naomi Matsukawa, et al.
Annals of Surgical Oncology|July 9, 2025
Intratumoral Lipopolysaccharide Positivity Related to Tumor-Associated Macrophage Infiltration and Poor Prognosis in Esophageal Squamous Cell CarcinomaShintaro Uchida, Takehiko Yokobori, Kota Yanagisawa, et al.
Oncology Letters|February 1, 2024
Prognostic value of a modified‑immune scoring system in patients with pathological T4 colorectal cancerGendensuren Dorjkhorloo, Bilguun Erkhem-Ochir, Takuya Shiraishi, et al.
The EMBO Journal|September 22, 2020
Astrocytic phagocytosis is a compensatory mechanism for microglial dysfunctionHiroyuki Konishi, Takayuki Okamoto, Yuichiro Hara, et al.
Cancer Medicine|October 17, 2022
Clinical decisions by the molecular tumor board on comprehensive genomic profiling tests in Japan: A retrospective observational studyHidekazu Shirota, Keigo Komine, Masanobu Takahashi, et al.
Journal of Human Genetics|February 22, 2023
Management of patients with presumed germline pathogenic variant from tumor-only genomic sequencing: A retrospective analysis at a single facilityMaako Kawamura, Hidekazu Shirota, Tetsuya Niihori, et al.
Familial Cancer|February 3, 2026
Attenuated Li-Fraumeni syndrome with TP53 p.R181H in a Japanese patient with metastatic rectal adenocarcinoma: a case reportYuki Kasahara, Masanobu Takahashi, Yoshifumi Kawamura, et al.
Anticancer Research|June 26, 2024
Risks and Outcomes of Early Dose Reduction in Adjuvant CAPOX Therapy for Colorectal CancerIkuma Shioi, Hiroomi Ogawa, Ryozan Naito, et al.
Scientific Reports|December 27, 2024
High levels of fibrotic tumor components are associated with recurrence and intratumoral immune status in advanced colorectal cancer patientsGendensuren Dorjkhorloo, Takuya Shiraishi, Bilguun Erkhem-Ochir, et al.
Techniques in Coloproctology|May 23, 2025
Benefit of laparoscopic two-team transanal beyond total mesorectal excision for advanced and recurrent rectal cancer with invasion: a retrospective study compared with conventional laparoscopic approachIkuma Shioi, Takuya Shiraishi, Yutaro Shimizu, et al.
Pageof 96